Medically Reviewed and Compiled by Dr. Adam N. Khan, MD.
What Is Abiraterone?
The prostate cancer drug abiraterone is a prescription medicine used to treat advanced prostate cancer. It helps slow down cancer growth by lowering certain male hormones in the body.
Abiraterone is sold under the brand name Zytiga. It is approved by the U.S. Food and Dru
Medically Reviewed and Compiled by Dr. Adam N. Khan, MD.
What Is Abiraterone?
The prostate cancer drug abiraterone is a prescription medicine used to treat advanced prostate cancer. It helps slow down cancer growth by lowering certain male hormones in the body.
Abiraterone is sold under the brand name Zytiga. It is approved by the U.S. Food and Drug Administration (FDA) to treat specific stages of prostate cancer.
Doctors usually give abiraterone along with prednisone, a steroid medicine. This combination helps reduce side effects and improves treatment results.
How Prostate Cancer Grows
Prostate cancer depends on male hormones called androgens. The main androgen is testosterone.
Even when doctors lower testosterone with hormone shots (called androgen deprivation therapy or ADT), the body can still make small amounts of hormones in:
- The adrenal glands
- The tumor itself
These leftover hormones can continue to feed the cancer.
That is where abiraterone works.
How Abiraterone Works
Abiraterone blocks an enzyme called CYP17. This enzyme helps the body make androgens.
By blocking CYP17, abiraterone:
- Lowers testosterone levels further
- Reduces hormone production in the adrenal glands
- Decreases hormone production inside cancer cells
According to the National Cancer Institute, abiraterone significantly lowers androgen levels in men with advanced prostate cancer.
This deeper hormone suppression can slow tumor growth and improve survival.
Who Should Take Abiraterone?
Abiraterone is used for men with:
1. Metastatic Castration-Resistant Prostate Cancer (mCRPC)
This means:
- Cancer has spread
- Testosterone is already low
- Cancer still grows
2. Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
In this stage:
- Cancer has spread
- It still responds to hormone therapy
The American Cancer Society confirms abiraterone is used in both settings depending on disease stage.
Major Clinical Trials Supporting Abiraterone
COU-AA-301 Trial
This study tested abiraterone in men whose cancer worsened after chemotherapy.
Published in the New England Journal of Medicine, the trial showed:
- Improved overall survival
- Better symptom control
- Delayed cancer progression
LATITUDE Trial
This trial studied men with newly diagnosed metastatic prostate cancer.
Results showed:
- Longer survival
- Delayed need for chemotherapy
- Reduced disease progression
These findings led to expanded FDA approval.
How Abiraterone Is Taken
- Taken as a tablet by mouth
- Usually once daily
- Must be taken on an empty stomach
- Always taken with prednisone
Food increases absorption too much. That can increase side effects.
Doctors also continue testosterone-lowering therapy during treatment.
Benefits of Abiraterone
According to the Mayo Clinic, benefits may include:
- Longer survival
- Slower disease progression
- Reduced bone pain
- Delayed chemotherapy
- Improved quality of life
Many patients experience symptom relief, especially from bone metastases.
Common Side Effects
Because abiraterone changes hormone balance, it can cause side effects.
Mild to Moderate Effects
- Fatigue
- Joint pain
- Swelling in legs
- Hot flashes
- High blood pressure
More Serious Risks
- Low potassium
- Liver problems
- Fluid retention
- Heart rhythm changes
Prednisone helps reduce some hormone-related complications.
Regular blood tests are required.
Monitoring During Treatment
Doctors monitor:
- Liver function tests
- Potassium levels
- Blood pressure
- PSA levels
Monitoring ensures safe use and early detection of complications.
Drug Interactions
Abiraterone may interact with:
- Blood pressure medicines
- Certain heart medications
- Some seizure drugs
Always tell your doctor about all medications and supplements.
Unique Clinical Takeaways
1. Cardiovascular Risk Assessment Before Starting Treatment
Abiraterone can raise blood pressure and cause fluid retention. Men with:
- Heart disease
- Prior heart attack
- Irregular heartbeat
- Severe high blood pressure
Need careful screening.
A baseline heart evaluation may include:
- Blood pressure review
- Electrocardiogram (ECG)
- Electrolyte testing
Men with uncontrolled cardiac disease may need stabilization before starting therapy.
This step is often underemphasized but critical for safety.
2. Distinguishing Liver Toxicity From Disease Progression
Abiraterone can raise liver enzymes. However, advanced prostate cancer can also spread to the liver.
If liver tests rise, doctors must determine:
- Drug-related toxicity
- Cancer progression
- Other liver disease
Management differs greatly:
- Drug toxicity may require dose hold
- Metastatic spread may require therapy change
Close laboratory monitoring helps guide decisions.
3. Adherence and Fasting Requirements Matter More Than Patients Realize
Abiraterone must be taken on an empty stomach.
If taken with food:
- Drug levels increase unpredictably
- Side effects increase
- Safety risks rise
Some patients unknowingly take it with breakfast.
Clear education is essential:
- Take at least 1 hour before eating
- Or 2 hours after food
Proper timing directly affects outcomes.
4. Bone Health Management Should Begin Early
Advanced prostate cancer weakens bones.
Long-term hormone therapy increases fracture risk.
Doctors may recommend:
- Bone density testing
- Calcium and vitamin D
- Bone-strengthening medicines
Bone complications can reduce mobility and survival.
Early prevention improves long-term outcomes.
When Abiraterone May Not Be Appropriate
Abiraterone may not be suitable for:
- Severe liver disease
- Uncontrolled heart failure
- Severe low potassium
Treatment decisions depend on overall health, cancer stage, and patient preference.
Comparison With Other Hormone Drugs
Other androgen-targeting drugs include:
- Enzalutamide
- Apalutamide
- Darolutamide
Abiraterone works differently by blocking hormone production rather than blocking hormone receptors.
Choice depends on:
- Disease stage
- Side effect profile
- Cost
- Insurance coverage
- Patient health status
Cost and Access Considerations
Abiraterone can be expensive. Generic versions are available.
Insurance often covers it when medically necessary.
Patient assistance programs may reduce costs.
Quality of Life Considerations
Many men stay active while taking abiraterone.
However, fatigue is common.
Lifestyle adjustments may include:
- Regular light exercise
- Balanced diet
- Blood pressure control
- Monitoring weight
Managing side effects improves daily functioning.
Long-Term Outlook
Abiraterone does not cure advanced prostate cancer.
It slows progression and extends survival.
Many patients eventually require additional treatments.
Combination therapy is common in modern care plans.
Ongoing research continues to refine optimal sequencing strategies.
References and Citations
- U.S. Food and Drug Administration – Abiraterone acetate prescribing information and approval data.
- National Cancer Institute – Hormone therapy for prostate cancer overview.
- American Cancer Society – Treatment options for advanced prostate cancer.
- New England Journal of Medicine – COU-AA-301 and LATITUDE trial publications on abiraterone survival outcomes.
- Mayo Clinic – Clinical overview of abiraterone uses, risks, and monitoring.
Medical Disclaimer
This article is for educational purposes only. It does not replace professional medical advice, diagnosis, or treatment. Patients should consult a licensed physician or oncology specialist before starting or changing any cancer therapy